Soo Park, MD, discusses her expectations for the upcoming 2023 AVAHO meeting in Chicago. Two items on the agenda particularly stand out: the role of artificial intelligence (AI) in oncology and the importance of cancer patient navigation. Dr Park acknowledges AI's potential to transform cancer diagnostics and drug discovery, particularly in aiding molecular profiling. Additionally, she highlights the value of cancer patient navigators in optimizing veteran care, particularly in the setting of geriatric oncology.
AVAHO 2023: Exploring AI and Cancer Navigation for Veterans
Soo Park, MD, Associate Professor, UC San Diego Health and VA San Diego Medical Center, La Jolla, California
Soo Park, MD, has disclosed the following relevant financial relationships: Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Regeneron